JanetAlvarezMD

General Surgery • New York, NY

Physician

Join to view full profile

Dr. Alvarez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alvarez's full profile

Already have an account?

Office
417 E 68th St
New York, NY 10065

Education & Training

New York Medical College at Metropolitan Hospital CenterResidency, Surgery, 2019 - 2021
Rutgers New Jersey Medical SchoolClass of 2019

Publications & Presentations

PubMed

Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker Selection.
Wei Zhang, Chao Wu, Hanchen Huang, Paulina Bleu, Wini Zambare
Medrxiv. 2024-05-09
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinic...
J Alvarez, Q Shi, A Dasari, J Garcia-Aguilar, H Sanoff
Medrxiv. 2024-04-27
Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived Organoid.
Hanchen Huang, Chao Wu, Antonio Colaprico, Paulina Bleu, Wini Zambare
Medrxiv. 2024-01-30

Journal Articles

Watch-and-Wait Approach to Rectal Cancer: The Role of Imaging
Vetri Sudar Jayaprakasam, Janet Alvarez, Dana M Omer, Marc J Gollub, J Joshua Smith, Iva Petkovska, Radiology, 3/7/2023
Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis
Janet Alvarez, Koushik K Das, Kiron M Das, Elizabeth Poplin, Darren N Seril, Digestive Diseases and Sciences

Press Mentions

ctDNA Monitoring Shows Promise for Anal Cancer Patients Receiving ChemoradiationJanuary 22nd, 2023
New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
New Signatera™ MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023